Worldwide sepsis diagnostics market is estimated to amass around US $1,033.02 million by the year 2026, according to the latest research available at Market Study Report, report provides extensively data on market share, growth, trends and forecasts for the period 2017-2026.
 

Sepsis is a lethal organ dysfunction condition that arises when the body responds to an infection in its own organs and tissues. The disorder is triggered by a weakened immune system, liver or kidney disease, chronic illnesses like cancer, and severe wounds. Sepsis is generally of two types – septic shock, in which there are indications of severe and low blood pressure, and the other one being severe sepsis, which causes organ failure.
 

As per the report, the burgeoning number of people affected with sepsis, the growing demand for proper diagnosis and treatment of the disorder, and the surging number of HIA (hospital-acquired infections) are expected to boost the sepsis diagnostics market growth. Usually, the hospital-acquired infections are surgical site and urinary tract infections, that lead to sepsis. Based on the data gathered by the WHO (World Health Organization), seven out of hundred hospitalized individuals acquire these infections in the developed economies, which in turn, boosts the demand for appropriate diagnosis and further supports market growth. In addition, pneumonia is a leading factor driving the demand for sepsis diagnostics, as it is one of the primary causes of septic shock.
 

The product spectrum of the global sepsis diagnostics market comprises instruments, assay kits & reagents, and blood culture media. Reportedly, the blood culture media segment is anticipated to amass significant market share over the projected period. The blood culture method is highly cost-effective and is ruminated as the gold standard method.  
 

By technology, the global market can be bifurcated into molecular diagnostics, microbiology, flow cytometry, and immunoassays. According to the report, the microbiology segment is anticipated to lead the market, as it helps in identification and quantitative detection of microbes for sepsis diagnosis.
 

Request sample copy of this Report@ https://www.marketstudyreport.com/request-a-sample/1695088/
 

Based on the pathogen type, the global market is fragmented into bacterial sepsis and fungal sepsis, wherein bacterial sepsis is further classified into gram-positive bacteria and gram-negative bacteria. The bacterial sepsis segment will be a major contributor, as blood poisoning is caused due to bacterial infection.
 

Speaking of the test type, the worldwide market is categorized into PoC testing and laboratory testing. The laboratory testing segment dominated the global market in 2017, cites the report.
 

The broad competitive spectrum of the global sepsis diagnostics market encompasses renowned companies such as Dickinson and Company, Thermo Fisher Scientific Inc., Roche Diagnostics, Cepheid Inc., Nanosphere Inc., Becton, Beckman Coulter Inc., and Bruker Corporation, and several others.
 

The report further analyses these market players, in view of their strong points, business tactics, and market performance. The company profiles of these players, along with their business overview, product benchmarking, financials, and recent developments, has also been included in the report.